UY39466A - Compuestos y composiciones para el tratamiento de la criptosporidiosis - Google Patents
Compuestos y composiciones para el tratamiento de la criptosporidiosisInfo
- Publication number
- UY39466A UY39466A UY0001039466A UY39466A UY39466A UY 39466 A UY39466 A UY 39466A UY 0001039466 A UY0001039466 A UY 0001039466A UY 39466 A UY39466 A UY 39466A UY 39466 A UY39466 A UY 39466A
- Authority
- UY
- Uruguay
- Prior art keywords
- compounds
- cryptosporidiosis
- treatment
- compositions
- symptomatology
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La invención se refiere a compuestos de Formula I o una sal farmacéuticamente aceptable, un tautómero o estereoisómero de dichos compuestos, en donde las variables son como se definen en el presente documento. La presente invención proporciona además composiciones farmacéuticas que comprenden dichos compuestos, y métodos de uso de dichos compuestos para el método de tratamiento, prevención, inhibición, mejora o erradicación de la patología y/o sintomatología de la criptosporidiosis mediante la administración de dicho compuesto.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063091866P | 2020-10-14 | 2020-10-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY39466A true UY39466A (es) | 2022-05-31 |
Family
ID=78302850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001039466A UY39466A (es) | 2020-10-14 | 2021-10-12 | Compuestos y composiciones para el tratamiento de la criptosporidiosis |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12018024B2 (es) |
| EP (1) | EP4229055A1 (es) |
| JP (1) | JP2023545452A (es) |
| CN (1) | CN116368137A (es) |
| AR (1) | AR123766A1 (es) |
| AU (1) | AU2021362803A1 (es) |
| CA (1) | CA3197199A1 (es) |
| MX (1) | MX2023004435A (es) |
| TW (1) | TW202229277A (es) |
| UY (1) | UY39466A (es) |
| WO (1) | WO2022079616A1 (es) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3012107A1 (en) * | 2016-01-21 | 2017-07-27 | Novartis Ag | Compounds and compositions for the treatment of cryptosporidiosis |
-
2021
- 2021-10-12 AR ARP210102815A patent/AR123766A1/es unknown
- 2021-10-12 CA CA3197199A patent/CA3197199A1/en active Pending
- 2021-10-12 EP EP21794994.0A patent/EP4229055A1/en active Pending
- 2021-10-12 WO PCT/IB2021/059376 patent/WO2022079616A1/en active Application Filing
- 2021-10-12 CN CN202180069247.7A patent/CN116368137A/zh active Pending
- 2021-10-12 AU AU2021362803A patent/AU2021362803A1/en active Pending
- 2021-10-12 UY UY0001039466A patent/UY39466A/es unknown
- 2021-10-12 JP JP2023522570A patent/JP2023545452A/ja active Pending
- 2021-10-12 TW TW110137677A patent/TW202229277A/zh unknown
- 2021-10-12 US US17/499,663 patent/US12018024B2/en active Active
- 2021-10-12 MX MX2023004435A patent/MX2023004435A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2023004435A (es) | 2023-05-08 |
| AU2021362803A1 (en) | 2023-06-01 |
| AR123766A1 (es) | 2023-01-11 |
| US12018024B2 (en) | 2024-06-25 |
| WO2022079616A1 (en) | 2022-04-21 |
| CN116368137A (zh) | 2023-06-30 |
| EP4229055A1 (en) | 2023-08-23 |
| CA3197199A1 (en) | 2022-04-21 |
| US20220112189A1 (en) | 2022-04-14 |
| JP2023545452A (ja) | 2023-10-30 |
| TW202229277A (zh) | 2022-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2022010460A2 (es) | Compuestos tricíclicos sustituidos | |
| CO2022008997A2 (es) | Compuestos tricíclicos sustituidos | |
| CL2022001625A1 (es) | Derivados de pirazolilo útiles como agentes anti-cancerígenos | |
| ECSP22019360A (es) | Piperidinil-metil-purinaminas como inhibidores de nsd2 y antineoplásicos | |
| AR108046A1 (es) | Derivados de indolina sustituidos como inhibidores de la replicación viral del dengue | |
| UY35400A (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
| UY35146A (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
| DOP2024000039A (es) | Derivados de quinolina como inhibidores de la integrina alfa4beta7 | |
| EA201991894A1 (ru) | ПИПЕРИДИН-ЗАМЕЩЕННЫЕ ИНГИБИТОРЫ Mnk И СВЯЗАННЫЕ С НИМИ СПОСОБЫ | |
| CO2023001668A2 (es) | Derivados de 1h-benzo[d]imidazol como inhibidores de tlr9 para el tratamiento de fibrosis | |
| CO2021014210A2 (es) | Compuestos de pirrol | |
| MX2020013297A (es) | Compuestos para el tratamiento o la prevencion de enfermedades hepaticas. | |
| CO2019004004A2 (es) | Composición farmacéutica y método para el tratamiento de la enfermedad del hígado graso no alcohólico | |
| UY39181A (es) | COMPUESTOS Y COMPOSICIONES PARA INHIBIR LA ACTIVIDAD DE HIF2a Y SUS MÉTODOS DE USO | |
| CR20160334A (es) | Derivados de [1,2,4]triazol[1,5-a]pirimidina como inhibidores de proteasoma para el tratamiento de enfermedades parasitarias tales como leishmaniasis | |
| CO2022008616A2 (es) | Composición farmacéutica oral que comprende compuesto de carbamato y método de preparación para la misma | |
| CO2023001407A2 (es) | Compuestos de tetrahidropirazolo-pirazinil-dihidroimidazolona o tetrahidropirazolo-piridinil-dihidroimidazolona y métodos de uso de los mismos | |
| ECSP19084722A (es) | Compuestos bicíclicos 5,6-fusionados y composiciones para el tratamiento de enfermedades parasitarias | |
| EA202192760A1 (ru) | Трициклические соединения | |
| AR128109A1 (es) | Spiros y análogos relacionados para inhibir yap / taz-tead | |
| UY39466A (es) | Compuestos y composiciones para el tratamiento de la criptosporidiosis | |
| UY39625A (es) | Derivados tricíclicos útiles como inhibidores de parp7 | |
| MX2022011242A (es) | Inmunomodulación de o-het/aril azálidos. | |
| AR119317A1 (es) | Un derivado de tetrahidroisoquinolina sustituido como modulador alostérico positivo de d1 | |
| CO2024002712A2 (es) | Azálidos inmunomoduladores |